AQST - Aquestive Therapeutics Inc. (AQST) CEO Keith Kendall on Q4 2018 Results - Earnings Call Transcript
Aquestive Therapeutics, Inc. (AQST)
Q4 2018 Earnings Conference Call
March 14, 2019 08:00 AM ET
Company Participants
Lauren Walrath - Head, Corporate Marketing and Communications
Keith Kendall - Chief Executive Officer
Ken Marshall - Chief Commercial Officer
Dan Barber - Chief Strategy and Development Officer
John Maxwell - Chief Financial Officer
Conference Call Participants
Gary Nachman - BMO Capital Markets
Randall Stanicky - RBC Capital Markets
Liana Moussatos - Wedbush Securities
Douglas Buchanan - JMP Securities
Thomas Flaten - Lake Street Capital Markets
Edward White - H.C. Wainwright
Presentation
Operator
Good morning, and welcome to